Shire Owes $45M Milestone After Life Science Acquisition

Law360 (October 13, 2020, 10:22 PM EDT) -- Pharmaceutical company Shire owes $45 million in a post-merger milestone payment to the shareholders of a life science company it acquired in 2012, the Delaware Chancery Court found on Tuesday.

Shire U.S. Holdings Inc. and Shire Pharmaceuticals LLC can't lean on an exception to the agreement that would have allowed it to escape making the milestone payment, Vice Chancellor Kathaleen McCormick ruled. The opinion allows the former shareholders of FerroKin BioSciences Inc. to receive the payment as well as interest and their legal costs.

The decision follows a four-day trial earlier this year.

The dispute centers around a merger deal struck...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!